Business Description
Adimmune Corp
ISIN : TW0004142005
Total Employee Number:
564Description
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.79 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | -33.8 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.65 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.2 | |||||
3-Year FCF Growth Rate | 27 | |||||
3-Year Book Growth Rate | -6.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.58 | |||||
9-Day RSI | 61.16 | |||||
14-Day RSI | 56.8 | |||||
3-1 Month Momentum % | -8.47 | |||||
6-1 Month Momentum % | -9.66 | |||||
12-1 Month Momentum % | 2.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 1.45 | |||||
Days Inventory | 236.11 | |||||
Days Sales Outstanding | 59.19 | |||||
Days Payable | 18.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -2.38 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.58 | |||||
Operating Margin % | -23.06 | |||||
Net Margin % | -17.12 | |||||
EBITDA Margin % | -5.98 | |||||
FCF Margin % | -17.28 | |||||
OCF Margin % | -0.39 | |||||
ROE % | -4.86 | |||||
ROA % | -2.88 | |||||
ROIC % | -5.25 | |||||
3-Year ROIIC % | -120.02 | |||||
ROC (Joel Greenblatt) % | -6.14 | |||||
ROCE % | -4.37 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.5 | |||||
PB Ratio | 1.51 | |||||
Price-to-Tangible-Book | 1.53 | |||||
Price-to-Operating-Cash-Flow | 356 | |||||
EV-to-EBIT | -27.46 | |||||
EV-to-EBITDA | -97.93 | |||||
EV-to-Revenue | 5.85 | |||||
EV-to-FCF | -32.13 | |||||
Price-to-GF-Value | 0.7 | |||||
Price-to-Projected-FCF | 2.59 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 356 | |||||
Earnings Yield (Greenblatt) % | -3.64 | |||||
FCF Yield % | -3.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adimmune Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,401.501 | ||
| EPS (TTM) (NT$) | -0.57 | ||
| Beta | 0.042 | ||
| 3-Year Sharpe Ratio | -1.29 | ||
| 3-Year Sortino Ratio | -1.4 | ||
| Volatility % | 12.87 | ||
| 14-Day RSI | 56.8 | ||
| 14-Day ATR (NT$) | 0.409167 | ||
| 20-Day SMA (NT$) | 17.475 | ||
| 12-1 Month Momentum % | 2.37 | ||
| 52-Week Range (NT$) | 15.95 - 22.5 | ||
| Shares Outstanding (Mil) | 421.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adimmune Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adimmune Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adimmune Corp Frequently Asked Questions
What is Adimmune Corp(TPE:4142)'s stock price today?
The current price of TPE:4142 is NT$17.80. The 52 week high of TPE:4142 is NT$22.50 and 52 week low is NT$15.95.
When is next earnings date of Adimmune Corp(TPE:4142)?
The next earnings date of Adimmune Corp(TPE:4142) is .
Does Adimmune Corp(TPE:4142) pay dividends? If so, how much?
Adimmune Corp(TPE:4142) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Adimmune Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers